<italic toggle="yes">Fusobacterium nucleatum</italic> Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation

ABSTRACT Multiple studies have implicated microbes in the development of inflammation, but the mechanisms remain unknown. Bacteria in the genus Fusobacterium have been identified in the intestinal mucosa of patients with digestive diseases; thus, we hypothesized that Fusobacterium nucleatum promotes...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Melinda A. Engevik, Heather A. Danhof, Wenly Ruan, Amy C. Engevik, Alexandra L. Chang-Graham, Kristen A. Engevik, Zhongcheng Shi, Yanling Zhao, Colleen K. Brand, Evan S. Krystofiak, Susan Venable, Xinli Liu, Kendal D. Hirschi, Joseph M. Hyser, Jennifer K. Spinler, Robert A. Britton, James Versalovic
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/ebd421ea1ed24b248d975fb71e9bd169
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ebd421ea1ed24b248d975fb71e9bd169
record_format dspace
spelling oai:doaj.org-article:ebd421ea1ed24b248d975fb71e9bd1692021-11-10T18:37:48Z<italic toggle="yes">Fusobacterium nucleatum</italic> Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation10.1128/mBio.02706-202150-7511https://doaj.org/article/ebd421ea1ed24b248d975fb71e9bd1692021-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.02706-20https://doaj.org/toc/2150-7511ABSTRACT Multiple studies have implicated microbes in the development of inflammation, but the mechanisms remain unknown. Bacteria in the genus Fusobacterium have been identified in the intestinal mucosa of patients with digestive diseases; thus, we hypothesized that Fusobacterium nucleatum promotes intestinal inflammation. The addition of >50 kDa F. nucleatum conditioned media, which contain outer membrane vesicles (OMVs), to colonic epithelial cells stimulated secretion of the proinflammatory cytokines interleukin-8 (IL-8) and tumor necrosis factor (TNF). In addition, purified F. nucleatum OMVs, but not compounds <50 kDa, stimulated IL-8 and TNF production; which was decreased by pharmacological inhibition of Toll-like receptor 4 (TLR4). These effects were linked to downstream effectors p-ERK, p-CREB, and NF-κB. F. nucleatum >50-kDa compounds also stimulated TNF secretion, p-ERK, p-CREB, and NF-κB activation in human colonoid monolayers. In mice harboring a human microbiota, pretreatment with antibiotics and a single oral gavage of F. nucleatum resulted in inflammation. Compared to mice receiving vehicle control, mice treated with F. nucleatum showed disruption of the colonic architecture, with increased immune cell infiltration and depleted mucus layers. Analysis of mucosal gene expression revealed increased levels of proinflammatory cytokines (KC, TNF, IL-6, IFN-γ, and MCP-1) at day 3 and day 5 in F. nucleatum-treated mice compared to controls. These proinflammatory effects were absent in mice who received F. nucleatum without pretreatment with antibiotics, suggesting that an intact microbiome is protective against F. nucleatum-mediated immune responses. These data provide evidence that F. nucleatum promotes proinflammatory signaling cascades in the context of a depleted intestinal microbiome. IMPORTANCE Several studies have identified an increased abundance of Fusobacterium in the intestinal tracts of patients with colon cancer, liver cirrhosis, primary sclerosing cholangitis, gastroesophageal reflux disease, HIV infection, and alcoholism. However, the direct mechanism(s) of action of Fusobacterium on pathophysiological within the gastrointestinal tract is unclear. These studies have identified that F. nucleatum subsp. polymorphum releases outer membrane vesicles which activate TLR4 and NF-κB to stimulate proinflammatory signals in vitro. Using mice harboring a human microbiome, we demonstrate that F. nucleatum can promote inflammation, an effect which required antibiotic-mediated alterations in the gut microbiome. Collectively, these results suggest a mechanism by which F. nucleatum may contribute to intestinal inflammation.Melinda A. EngevikHeather A. DanhofWenly RuanAmy C. EngevikAlexandra L. Chang-GrahamKristen A. EngevikZhongcheng ShiYanling ZhaoColleen K. BrandEvan S. KrystofiakSusan VenableXinli LiuKendal D. HirschiJoseph M. HyserJennifer K. SpinlerRobert A. BrittonJames VersalovicAmerican Society for MicrobiologyarticleFusobacterium nucleatumenteroidsorganoidsinflammationouter membrane vesiclesTLR4MicrobiologyQR1-502ENmBio, Vol 12, Iss 2 (2021)
institution DOAJ
collection DOAJ
language EN
topic Fusobacterium nucleatum
enteroids
organoids
inflammation
outer membrane vesicles
TLR4
Microbiology
QR1-502
spellingShingle Fusobacterium nucleatum
enteroids
organoids
inflammation
outer membrane vesicles
TLR4
Microbiology
QR1-502
Melinda A. Engevik
Heather A. Danhof
Wenly Ruan
Amy C. Engevik
Alexandra L. Chang-Graham
Kristen A. Engevik
Zhongcheng Shi
Yanling Zhao
Colleen K. Brand
Evan S. Krystofiak
Susan Venable
Xinli Liu
Kendal D. Hirschi
Joseph M. Hyser
Jennifer K. Spinler
Robert A. Britton
James Versalovic
<italic toggle="yes">Fusobacterium nucleatum</italic> Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation
description ABSTRACT Multiple studies have implicated microbes in the development of inflammation, but the mechanisms remain unknown. Bacteria in the genus Fusobacterium have been identified in the intestinal mucosa of patients with digestive diseases; thus, we hypothesized that Fusobacterium nucleatum promotes intestinal inflammation. The addition of >50 kDa F. nucleatum conditioned media, which contain outer membrane vesicles (OMVs), to colonic epithelial cells stimulated secretion of the proinflammatory cytokines interleukin-8 (IL-8) and tumor necrosis factor (TNF). In addition, purified F. nucleatum OMVs, but not compounds <50 kDa, stimulated IL-8 and TNF production; which was decreased by pharmacological inhibition of Toll-like receptor 4 (TLR4). These effects were linked to downstream effectors p-ERK, p-CREB, and NF-κB. F. nucleatum >50-kDa compounds also stimulated TNF secretion, p-ERK, p-CREB, and NF-κB activation in human colonoid monolayers. In mice harboring a human microbiota, pretreatment with antibiotics and a single oral gavage of F. nucleatum resulted in inflammation. Compared to mice receiving vehicle control, mice treated with F. nucleatum showed disruption of the colonic architecture, with increased immune cell infiltration and depleted mucus layers. Analysis of mucosal gene expression revealed increased levels of proinflammatory cytokines (KC, TNF, IL-6, IFN-γ, and MCP-1) at day 3 and day 5 in F. nucleatum-treated mice compared to controls. These proinflammatory effects were absent in mice who received F. nucleatum without pretreatment with antibiotics, suggesting that an intact microbiome is protective against F. nucleatum-mediated immune responses. These data provide evidence that F. nucleatum promotes proinflammatory signaling cascades in the context of a depleted intestinal microbiome. IMPORTANCE Several studies have identified an increased abundance of Fusobacterium in the intestinal tracts of patients with colon cancer, liver cirrhosis, primary sclerosing cholangitis, gastroesophageal reflux disease, HIV infection, and alcoholism. However, the direct mechanism(s) of action of Fusobacterium on pathophysiological within the gastrointestinal tract is unclear. These studies have identified that F. nucleatum subsp. polymorphum releases outer membrane vesicles which activate TLR4 and NF-κB to stimulate proinflammatory signals in vitro. Using mice harboring a human microbiome, we demonstrate that F. nucleatum can promote inflammation, an effect which required antibiotic-mediated alterations in the gut microbiome. Collectively, these results suggest a mechanism by which F. nucleatum may contribute to intestinal inflammation.
format article
author Melinda A. Engevik
Heather A. Danhof
Wenly Ruan
Amy C. Engevik
Alexandra L. Chang-Graham
Kristen A. Engevik
Zhongcheng Shi
Yanling Zhao
Colleen K. Brand
Evan S. Krystofiak
Susan Venable
Xinli Liu
Kendal D. Hirschi
Joseph M. Hyser
Jennifer K. Spinler
Robert A. Britton
James Versalovic
author_facet Melinda A. Engevik
Heather A. Danhof
Wenly Ruan
Amy C. Engevik
Alexandra L. Chang-Graham
Kristen A. Engevik
Zhongcheng Shi
Yanling Zhao
Colleen K. Brand
Evan S. Krystofiak
Susan Venable
Xinli Liu
Kendal D. Hirschi
Joseph M. Hyser
Jennifer K. Spinler
Robert A. Britton
James Versalovic
author_sort Melinda A. Engevik
title <italic toggle="yes">Fusobacterium nucleatum</italic> Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation
title_short <italic toggle="yes">Fusobacterium nucleatum</italic> Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation
title_full <italic toggle="yes">Fusobacterium nucleatum</italic> Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation
title_fullStr <italic toggle="yes">Fusobacterium nucleatum</italic> Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation
title_full_unstemmed <italic toggle="yes">Fusobacterium nucleatum</italic> Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation
title_sort <italic toggle="yes">fusobacterium nucleatum</italic> secretes outer membrane vesicles and promotes intestinal inflammation
publisher American Society for Microbiology
publishDate 2021
url https://doaj.org/article/ebd421ea1ed24b248d975fb71e9bd169
work_keys_str_mv AT melindaaengevik italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT heatheradanhof italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT wenlyruan italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT amycengevik italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT alexandralchanggraham italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT kristenaengevik italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT zhongchengshi italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT yanlingzhao italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT colleenkbrand italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT evanskrystofiak italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT susanvenable italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT xinliliu italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT kendaldhirschi italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT josephmhyser italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT jenniferkspinler italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT robertabritton italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
AT jamesversalovic italictoggleyesfusobacteriumnucleatumitalicsecretesoutermembranevesiclesandpromotesintestinalinflammation
_version_ 1718439936254803968